F. Jeffrey Lorenz MD, Andrew J. Rothka BS, Heather K. Schopper MD, Jessyka G. Lighthall MD, FACS
{"title":"COVID-19 对面部整形手术量的影响：大流行前后趋势的大型数据库分析。","authors":"F. Jeffrey Lorenz MD, Andrew J. Rothka BS, Heather K. Schopper MD, Jessyka G. Lighthall MD, FACS","doi":"10.1002/lio2.1292","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Objective</h3>\n \n <p>During the COVID-19 pandemic, elective surgeries faced cancelations due to quarantine measures. The objective of this study was to assess facial plastic and reconstructive surgery (FPRS) volume before, during, and after the height of the pandemic on a national scale.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>The TriNetX Research Network identified 68,101,098 individuals aged 18+ with healthcare interactions from 2017 to 2022. Rates of common FPRS surgeries and procedures were compared during March–August of each year, aligning with the pandemic lockdown.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Compared to immediately before the pandemic in 2019, the 2020 pandemic peak saw an overall surgical volume reduction of −36.8%, with specific surgeries decreasing significantly: rhinoplasty (−28.6%), septoplasty (−34.0%), rhytidectomy (−54.9%), blepharoplasty (−40.7%), brow lift (−43.8%), ectropion/entropion repair (−35.6%), repair of blepharoptosis (−45.6%), correction of lagophthalmos (−29.9%), correction of lid retraction (−36.8%), and lipectomy (−41.8%) (<i>p</i> < .001). The procedural volume also decreased by 28.6%, encompassing reductions in various procedures: botulinum toxin A (−18.7%), facial filler (−40.7%), dermabrasion (−62.3%), chemical peel (−36.6%), and intralesional injection (−33.3%) (<i>p</i> < .001). In contrast to 2020, 2021 witnessed an increase of +75.0% in total surgical and +61.3% procedural volume: rhinoplasty (+81.0%), septoplasty (+74.7%), rhytidectomy (+143.4%), blepharoplasty (+81.7%), brow lift (+64.5%), ectropion/entropion repair (+55.2%), repair of blepharoptosis (+62.7%), correction of lagophthalmos (+39.0%), correction of lid retraction (+73.0%), lipectomy (+121.2%), botulinum toxin A (+52.4%), filler (+59.6%), dermabrasion (+91.8%), chemical peel (+78.8%), and intralesional injection (+67.3%) (<i>p</i> < .001). In 2022, rates of total surgeries (+8.5%) and procedures (+12.8%) surpassed pre-pandemic levels from 2019 (<i>p</i> < .001).</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>FPRS experienced significant pandemic-induced decreases, followed by a notable recovery in subsequent years, with certain surgeries and procedures surpassing pre-pandemic levels.</p>\n </section>\n \n <section>\n \n <h3> Level of Evidence</h3>\n \n <p>4.</p>\n </section>\n </div>","PeriodicalId":48529,"journal":{"name":"Laryngoscope Investigative Otolaryngology","volume":"9 3","pages":""},"PeriodicalIF":1.6000,"publicationDate":"2024-06-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11166095/pdf/","citationCount":"0","resultStr":"{\"title\":\"Impact of COVID-19 on facial plastic surgery volumes: A large database analysis of pre- and post-pandemic trends\",\"authors\":\"F. Jeffrey Lorenz MD, Andrew J. Rothka BS, Heather K. Schopper MD, Jessyka G. Lighthall MD, FACS\",\"doi\":\"10.1002/lio2.1292\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n \\n \\n <section>\\n \\n <h3> Objective</h3>\\n \\n <p>During the COVID-19 pandemic, elective surgeries faced cancelations due to quarantine measures. The objective of this study was to assess facial plastic and reconstructive surgery (FPRS) volume before, during, and after the height of the pandemic on a national scale.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Methods</h3>\\n \\n <p>The TriNetX Research Network identified 68,101,098 individuals aged 18+ with healthcare interactions from 2017 to 2022. Rates of common FPRS surgeries and procedures were compared during March–August of each year, aligning with the pandemic lockdown.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Results</h3>\\n \\n <p>Compared to immediately before the pandemic in 2019, the 2020 pandemic peak saw an overall surgical volume reduction of −36.8%, with specific surgeries decreasing significantly: rhinoplasty (−28.6%), septoplasty (−34.0%), rhytidectomy (−54.9%), blepharoplasty (−40.7%), brow lift (−43.8%), ectropion/entropion repair (−35.6%), repair of blepharoptosis (−45.6%), correction of lagophthalmos (−29.9%), correction of lid retraction (−36.8%), and lipectomy (−41.8%) (<i>p</i> < .001). The procedural volume also decreased by 28.6%, encompassing reductions in various procedures: botulinum toxin A (−18.7%), facial filler (−40.7%), dermabrasion (−62.3%), chemical peel (−36.6%), and intralesional injection (−33.3%) (<i>p</i> < .001). In contrast to 2020, 2021 witnessed an increase of +75.0% in total surgical and +61.3% procedural volume: rhinoplasty (+81.0%), septoplasty (+74.7%), rhytidectomy (+143.4%), blepharoplasty (+81.7%), brow lift (+64.5%), ectropion/entropion repair (+55.2%), repair of blepharoptosis (+62.7%), correction of lagophthalmos (+39.0%), correction of lid retraction (+73.0%), lipectomy (+121.2%), botulinum toxin A (+52.4%), filler (+59.6%), dermabrasion (+91.8%), chemical peel (+78.8%), and intralesional injection (+67.3%) (<i>p</i> < .001). In 2022, rates of total surgeries (+8.5%) and procedures (+12.8%) surpassed pre-pandemic levels from 2019 (<i>p</i> < .001).</p>\\n </section>\\n \\n <section>\\n \\n <h3> Conclusions</h3>\\n \\n <p>FPRS experienced significant pandemic-induced decreases, followed by a notable recovery in subsequent years, with certain surgeries and procedures surpassing pre-pandemic levels.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Level of Evidence</h3>\\n \\n <p>4.</p>\\n </section>\\n </div>\",\"PeriodicalId\":48529,\"journal\":{\"name\":\"Laryngoscope Investigative Otolaryngology\",\"volume\":\"9 3\",\"pages\":\"\"},\"PeriodicalIF\":1.6000,\"publicationDate\":\"2024-06-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11166095/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Laryngoscope Investigative Otolaryngology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/lio2.1292\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"OTORHINOLARYNGOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Laryngoscope Investigative Otolaryngology","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/lio2.1292","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"OTORHINOLARYNGOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
目的：在 COVID-19 大流行期间，择期手术因隔离措施而被取消。本研究的目的是在全国范围内评估大流行之前、期间和之后的面部整形和修复手术（FPRS）量：TriNetX研究网络确定了2017年至2022年期间与医疗保健互动的68,101,098名18岁以上的个人。比较了每年 3 月至 8 月期间常见的 FPRS 手术和程序的比率，这与大流行病封锁的时间一致：与 2019 年大流行前夕相比，2020 年大流行高峰期的总体手术量减少了 -36.8%，其中特定手术量明显减少：鼻成形术（-28.6%）、鼻中隔成形术（-34.0%）、皱襞切除术（-54.9%）、眼睑成形术（-40.7%）、提眉术（-43.8%）、外翻/内翻修复术（-35.6%）、睑外翻修复术（-45.6%）、眼睑下垂矫正术（-29.9%）、睑内翻矫正术（-36.8%）和唇切除术（-41.8%）（P P P P P 结论：FPRS经历了由大流行引起的显著下降，随后几年明显恢复，某些手术和程序超过了大流行前的水平：4.
Impact of COVID-19 on facial plastic surgery volumes: A large database analysis of pre- and post-pandemic trends
Objective
During the COVID-19 pandemic, elective surgeries faced cancelations due to quarantine measures. The objective of this study was to assess facial plastic and reconstructive surgery (FPRS) volume before, during, and after the height of the pandemic on a national scale.
Methods
The TriNetX Research Network identified 68,101,098 individuals aged 18+ with healthcare interactions from 2017 to 2022. Rates of common FPRS surgeries and procedures were compared during March–August of each year, aligning with the pandemic lockdown.
Results
Compared to immediately before the pandemic in 2019, the 2020 pandemic peak saw an overall surgical volume reduction of −36.8%, with specific surgeries decreasing significantly: rhinoplasty (−28.6%), septoplasty (−34.0%), rhytidectomy (−54.9%), blepharoplasty (−40.7%), brow lift (−43.8%), ectropion/entropion repair (−35.6%), repair of blepharoptosis (−45.6%), correction of lagophthalmos (−29.9%), correction of lid retraction (−36.8%), and lipectomy (−41.8%) (p < .001). The procedural volume also decreased by 28.6%, encompassing reductions in various procedures: botulinum toxin A (−18.7%), facial filler (−40.7%), dermabrasion (−62.3%), chemical peel (−36.6%), and intralesional injection (−33.3%) (p < .001). In contrast to 2020, 2021 witnessed an increase of +75.0% in total surgical and +61.3% procedural volume: rhinoplasty (+81.0%), septoplasty (+74.7%), rhytidectomy (+143.4%), blepharoplasty (+81.7%), brow lift (+64.5%), ectropion/entropion repair (+55.2%), repair of blepharoptosis (+62.7%), correction of lagophthalmos (+39.0%), correction of lid retraction (+73.0%), lipectomy (+121.2%), botulinum toxin A (+52.4%), filler (+59.6%), dermabrasion (+91.8%), chemical peel (+78.8%), and intralesional injection (+67.3%) (p < .001). In 2022, rates of total surgeries (+8.5%) and procedures (+12.8%) surpassed pre-pandemic levels from 2019 (p < .001).
Conclusions
FPRS experienced significant pandemic-induced decreases, followed by a notable recovery in subsequent years, with certain surgeries and procedures surpassing pre-pandemic levels.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
